RU-RB-01-01-21 of 08.02.2021
Multicenter, Open, Prospective, Randomized Trial of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
Постоянная ссылка: https://clinomir.ru/trials/nct/NCT04897113/
Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда
Простыми словами
Словарь терминов- В исследовании участвуют здоровые добровольцы.
- Статус исследования в реестре не указан — уточняйте в центре.
- Возраст участников: 40–55 лет. Остальные условия — в блоке «Кто может участвовать».
- По плану участвуют 80 чел. во всех странах исследования.
- Центров в реестре: 2 в 2 городах. Список — ниже на странице.
- Плановая дата окончания (12.2022) уже прошла.
Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.
Кто может участвовать
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 16 · невключение: 6
Критерии включения
- Signed informed consent form.
- Men and women aged 40-55.
- Body mass index <30 kg / m2.
- Level increase of one or several aging markers.
- Understanding of requirements for study participants, written consent to participate in the study (including volunteer's consent for his/her health information related to the study to be used and passed on) and to perform procedures outlined in study protocol.
- Negative pregnancy test for women of childbearing potential.
- Non-inclusion Criteria:
- Refusal to participate in the study.
- Any health conditions that, according to investigators, might prevent volunteers from participating in the study.
- Mental disorders, past medical history included.
- 10 + alcohol units per week (one alcohol unit equals 0,5 l of beer, 200 ml of wine or 50 ml of hard liquors) or any records of alcohol addiction.
- Drug addiction, chemical abuse.
- Pregnancy or breastfeeding.
- Past medical history of severe allergic reactions.
- General contraindications to plasmapheresis procedures.
- Any other health conditions or reasons that, according to investigators, might increase risks for participants or reduce the likelihood of results needed to meet the study goals.
Критерии невключения
- Voluntary refusal to participate in the study.
- Investigator doctor's decision on participant's exclusion for this participant's own benefit.
- Participant refuses to cooperate with investigator or is undisciplined.
- In case participant misses one or several study procedures or follow-up visits.
- Development of severe adverse reactions or severe diseases/conditions unrelated to the study, requiring withdrawal from therapy.
- Positive pregnancy test.
Источник: ClinicalTrials.gov, NCT04897113 · запись обновлена в реестре 21 мая 2021.
Дизайн и результаты
Что измеряют — первичные конечные точки (1), вторичных — 11
- Dynamics summary for improvement of aging biomarkers' values assessed by a patient's biochemical blood count — 1 month
Цель исследования
Reaching active aging makes it important to implement new methods affecting the biological age of a person. Biochemical parameters of a blood test are aging biomarkers that are ones of the most accessible for testing. We know that, with age, there is increase in levels of LDL, triglycerides, homocysteine and other biomarkers relating the body state.
Methods of extracorporeal hemocorrection showed good results in this area. For instance, the use of plasmapheresis is very effective during prophylaxis, treatment and rehabilitation after various diseases/injuries. The main effects of plasmapheresis are related to removal of endo- and exotoxins, including products of lipid peroxidation, and to draining effect as a result of a heavy flow of interstitial fluid containing products of pathometabolism into the blood stream within concentration gradient (by "dynamic equilibrium" in concentration of different substances in intracellular, interstitial and intravascular compartments). These effects are also related to release of receptors, their sensitization to their own neurohumoral regulation mechanisms, to insulin, in particular (as consequences, lower glucose tolerance, lower substrate glycation).
Где проходит
2 центра в 2 городахОткуда эта информация
-
ClinicalTrials.gov (U.S. National Library of Medicine) · NCT04897113 Официальный реестр (США) · загружено 9 ноября 2026Номер протокола, название, цель, сроки, число участников, спонсор, центры
Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.